Suzuken Co., Ltd. operates within the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Suzuken Co., Ltd. with three other
companies in this sector in Japan:
Alfresa Holdings Corporation
sales of 2.60 trillion Japanese Yen [US$22.91 billion]
of which 87%
was Wholesale Business of Pharmaceuticals fo),
Medipal Holdings Corporation
(3.15 trillion Japanese Yen [US$27.69 billion]
of which 67%
was Pharmaceuticals And Food Precessing Whol), and
Toho Holdings Company Limited
(1.21 trillion Japanese Yen [US$10.68 billion]
of which 92%
was Pharmaceutical Wholesale Business).
During the year ended March of 2018, sales at
Suzuken Co., Ltd. were ¥2.12 trillion (US$18.69 billion).
decrease of 0.1%
versus 2017, when the company's sales were ¥2.13 trillion.
Contributing to the drop in overall sales was the 20.0% decline
in Pharmaceutical Manufacturing Business, from ¥20.48 billion to ¥16.38 billion.
There were also decreases in sales in
Pharmaceutical Wholesale Business (down 0.1% to ¥1.98 trillion)
However, these declines were partially offset by the increase in sales of
Pharmacy Business Insurance (up 1.8% to ¥99.53 billion)
Medical-Related Business Services, Etc. (up 6.6% to ¥28.24 billion)